The Optimal Treatment Plan to Avoid Axillary Lymph Node Dissection in Early-Stage Breast Cancer Patients Differs by Surgical Strategy and Tumor Subtype

Documenti analoghi

• Is Preoperative Axillary Imaging Beneficial in Identifying Clinically Node-Negative Patients Requiring Axillary Lymph Node Dissection?
  di: Pilewskie, Melissa, et al.
  Pubblicazione: (2015)
• Does a positive axillary lymph node needle biopsy predict the need for an axillary lymph node dissection in clinically node-negative breast cancer patients in the ACOSOG Z0011 era?
  di: Pilewskie, Melissa, et al.
  Pubblicazione: (2015)
• Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients With Sentinel Lymph Node Metastases
  di: Mamtani, Anita, et al.
  Pubblicazione: (2016)
• Lobular Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG Z0011-Eligible Breast Cancers
  di: Mamtani, Anita, et al.
  Pubblicazione: (2019)
• Avoiding an Axillary Lymph Node Dissection: The Benefit of Neoadjuvant Chemotherapy for Occult Primary Breast Cancer
  di: van den Bruele, Astrid Botty, et al.
  Pubblicazione: (2020)